Tyler Blackwell

Tyler Blackwell is a board-certified medical physicist with extensive clinical experience in radiation therapy. He is active in several AAPM committees, has served as secretary-treasurer for the Northwest Chapter of AAPM, and is an ABR orals examiner.

赞助内容|Blog|Artificial Intelligence| June 07, 2021

BLOG: Auto-Segmentation in Radiation Oncology: Things to Consider

Automation is transforming the way we practiceradiation oncology提高病人护理水平。由于实现了护理路径各个部分的自动化,在工作流程和治疗质量方面都有了重大改进。

Contouring is a task that lends itself well to automation; it’s repetitive and tedious, yet requires skilled technical staffing. Often, critical OAR structures may be incompletely drawn or left out altogether to speed up this process, while manual contour errors may be missed due to user fatigue and an inefficient manual review process. So while auto-segmentation tools have been available for many years, widespread adoption of atlas-based solutions has been hindered by relatively high implementation costs and sub-par clinical results.

Recently, there is renewed excitement forauto-segmentation. The introduction of artificial intelligence and deep learning algorithms has allowed for more accessible, higher-quality, and consistent contours. Withartificial intelligence(AI) coming to the fore, it’s important to understand what’s involved in designing clinical tools and what to consider when evaluating various solutions for implementation.

Design Philosophy

While there is plenty of enthusiasm when it comes to AI and automation, it’s prudent to apply some scrutiny to the technology before wading into the deep end. We need to integrate new technologies in a way that ensures that clinicians — with irreplaceable clinical experience — remain front and center. Instead of removing humans from the equation, automation best serves clinical goals when it allows skilled professionals to apply their skills more efficiently. By simplifying routine and mundane tasks, automation paves the way for structured time savings, freeing trained staff to focus on higher-priority responsibilities that require human judgment.

软件设计师应该密切注意减少认知开销,或者减少理解所呈现信息所需的工作量。将时间和精力用于掌握不必要的复杂自动化工具或解释不清楚的结果是适得其反的。最好的工作流可以减少处理、导入/导出、单击和用户无关的手工输入的数量。

But still, putting clinical judgment to use is essential. Ideally, new tools incorporating automation are simple and easy to use without facilitating an over-reliance on the technology, enhancing clinician input as opposed to replacing it. Vendors have to carefully consider a design philosophy that provides efficiency and quality gains but also incorporates human review and input. Without the involvement of clinical experts, there is a risk of propagating errors in a systematic fashion. In the context of AI contouring, this is best achieved by incorporating or even requiring a standardized, documented review process for auto-generated structures.

What to Consider When Deciding on an AI Contouring Workflow

With AI contouring now gaining significant traction in the clinic, there are several items worth considering when deciding on which commercial tool best suits your department:

Time savings:There is a growing body of research1,2that has quantified time savings for different anatomical regions. Time savings varies on the individual organ models but is significant across the board. Furthermore, compared to atlas-based options,AI solutionstypically involve dramatically less up-front configuration to get started.

Workflow:With various options available, it’s important to understand how any given solution integrates with your clinical workflow. What types of images can be used for contours? Are any exports or imports required? If the tools are to be used by both dosimetrists and radiation oncologists, an intuitive and user-friendly interface is key.

Accuracy:The goal of auto-segmentation is to generate reliable, accurate contours in less time. So it’s fair to question: does it produce clinically useful contours most of the time? To go further, do the contours created by the models align with your clinical preferences? Fewer edits and inputs equate to more time savings.

Overcoming limitations:Even with the large improvements to AI contour models in the past few years, auto-generated outputs aren’t always perfect due to extremes in patient anatomy and setup. For those contours that require more attention, does the software allow for comprehensive (but efficient) review and editing?

Standardization:Variability in contours among planners is well-documented,3and discrepancies in structure volumes can potentially result in large deviations in dose delivery.ASTROhas developed initiatives and resources to encourage clinics to converge in delineation practices.4Does the software help to provide consistency in structures across all planners and physicians to achieve higher levels of standardization?

Commercial partnership:Deep-learning for auto-contouring is an emerging development and has plenty of room for growth and improvement. Has the commercial partner demonstrated they are capable of rapid quality improvement and a willingness to incorporate critical feedback? AI structure models built based on one clinic’s contour needs, may not match another’s.

Clearly, there is nuance involved in the adoption of new clinical technologies. But ultimately, there are demonstrated and tangible benefits to incorporating AI to streamline contouring inradiation therapy. Time savings can reveal new opportunities to provide value on high-impact clinical activities, and accelerating the treatment planning process translates to shortening the simulation-to-treatment timeline. Automating structure generation also creates a scaffolding for consistency and standardization. For these reasons, among many others, auto-segmentation is seeing a clinical renaissance in the age of AI.

Learn more about how your department can benefit from faster, automated contours atRadformation.com.

References:

1:https://doi.org/10.1016/j.radonc.2019.10.019

2:https://doi.org/10.1002/mp.13200

3:https://doi.org/10.1016/j.radonc.2016.09.009

4:https://doi.org/10.1016/j.prro.2018.12.003

Related Content

Research has potential to address significant unmet need, identify biomarkers that determine response to treatment
News|Lung Imaging

August 10, 2022 — Mount Sinai is leading a team of lung cancer researchers that has been awarded a three-year, $500,000 ...

TimeAugust 10, 2022
arrow
Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to significantly improve the accuracy and speed of prostate cancer detection (CADe) and diagnosis (CADx).
News|Prostate Cancer

August 9, 2022 — Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD ...

TimeAugust 09, 2022
arrow
The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV infusion for the treatment of patients with unresectable (unable to be removed) or metastatic (spread to other parts of the body) HER2-low breast cancer.
News|2022世界杯篮球预选赛赛程

August 8, 2022 — The U.S. Food and Drug Administration approved Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV ...

TimeAugust 08, 2022
arrow
Dr. Milena Cavic, Institute for Oncology and Radiology of Serbia
News|Lung Imaging

August 8, 2022 — Representatives from the Diagnostics Working Group of the IASLC Early Detection and Screening Committee ...

TimeAugust 08, 2022
arrow
David Gerber, MD
News|Lung Imaging

August 8, 2022 — A clinical trial is only as powerful as its participants. For years, researchers have struggled to fill ...

TimeAugust 08, 2022
arrow
Under this collaboration, IBA will equip the proton therapy system and the proton gantry treatment room at the Fred Hutchinson Cancer Center with ConformalFLASH research functionality, which will enable preclinical research on FLASH therapy.
News|Proton Therapy

August 5, 2022 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, Fred ...

TimeAugust 05, 2022
arrow
Enhancing oncology model aims to improve patient-centered care, lower health care costs, and address health equity as part of President Biden’s Cancer Moonshot
News|Radiology Business

August 4, 2022 — The Biden Administration, through the U.S. Department of Health and Human Services and the Centers for ...

TimeAugust 04, 2022
arrow
News|世界杯2022赛程时间表

August 3, 2022 — The Jack Martin Fund (JMF) has built on its partnership with the Mount Sinai Health System to provide ...

TimeAugust 03, 2022
arrow
The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to grow to $5.4 Bn by 2032, at a CAGR of 7.8% from 2022 to 2032.
Feature|Oncology Information Management Systems (OIMS)

August 2, 2022 — The oncology information systems market is projected to be worth $2.59 Bn by 2022 and is expected to ...

TimeAugust 02, 2022
arrow
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer, the leading cancer killer of women and men.
Feature|Lung Imaging

August 1, 2022 — In recognition of World Lung Cancer Day, the American Lung Association announced new patient resources ...

TimeAugust 01, 2022
arrow
Subscribe Now